Alpha Diagnostic is headquartered in San Antonio, Texas, US. It is a privately held biotechnology company focused on developing, manufacturing and supplying novel diagnostic and quality control reagents and test kits for use in basic human and animal biological and disease research.

Alpha Diagnostic develops and delivers diagnostic and validation solutions to promote global health through improved vaccine therapies and mitigate the spread of human and animal disease. They use unique technologies to produce a series of:

  • RecombiVirus ELISA kits based on purified,
  • recombinant viral
  • and bacterial antigens.

Kits are available for testing Ebola virus, MERS, HPV and meningitis B.

VacciGel ELISA kits are an innovative and industry-first test for the direct identification and measurement of vaccine components adsorbed onto alum adjuvants. The kits are available for testing hepatitis B, diphtheria, tetanus, pertussis, rabies and HCG (anti-fertility) vaccines.

Alpha Diagnostic focuses on improved vaccines for both humans and animals, humanised antibodies and drugs, rapid tests for veterinary research and diagnostics, consumer food testing, new sample transfer and validation systems, and primary antibodies for basic research. They produce reagents and instruments for immunology, cell biology and molecular biology in various research fields such as apoptosis, neuroscience of metabolism, plant biology and protein research, as well as stem cell research.